Repatha 140 MG/ML sureclickml
Ended Awarded
- Contract number
- SPE2DB25FUYGT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,960
Award facts
- Contract value 100% obligated
- $25,960.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors, valued at $25,960.48. This firm fixed price delivery order represents a non-competitive, non-set-aside award and carries an ultimate completion date of August 19, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location. This contract is issued as a child order under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as the primary vehicle for global pharmaceutical support to military healthcare programs.
Repatha (evolocumab) is a PCSK9 inhibitor prescribed for cholesterol management and cardiovascular disease prevention, representing a specialized pharmaceutical product within the Defense Health Agency's medical supply portfolio. The delivery order demonstrates AmerisourceBergen Drug Corp's continued role as a critical vendor for federal medical procurement, supplying brand-name medications across multiple therapeutic domains to support military and veteran healthcare systems. The company's extensive federal contract portfolio reflects its capability to fulfill competitive procurement requirements and serve as a primary distribution channel for pharmaceutical commodities across the Department of Defense medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FUYGT?
SPE2DB25FUYGT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 18, 2025.
How much is contract SPE2DB25FUYGT worth?
The government has obligated $25,960 on SPE2DB25FUYGT.
Is contract SPE2DB25FUYGT an order under another contract?
Yes. SPE2DB25FUYGT is a delivery order under SPE2DB25D3018, an indefinite delivery contract.
Was contract SPE2DB25FUYGT competed?
The extent of competition for SPE2DB25FUYGT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award